flumazenil has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 3 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Ramos, JA | 1 |
| López-Laso, E | 1 |
| Camino-León, R | 1 |
| Gascón-Jiménez, FJ | 1 |
| Jiménez-González, MD | 1 |
| Echaniz-Laguna, A | 1 |
| Degos, B | 1 |
| Bonnet, C | 1 |
| Latour, P | 1 |
| Hamadouche, T | 1 |
| Lévy, N | 1 |
| Leheup, B | 1 |
| Baránková, L | 1 |
| Sisková, D | 1 |
| Hühne, K | 1 |
| Vyhnálková, E | 1 |
| Sakmaryová, I | 1 |
| Bojar, M | 1 |
| Rautenstrauss, B | 1 |
| Seeman, P | 1 |
3 other studies available for flumazenil and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
[Experience in molecular diagnostic in hereditary neuropathies in a pediatric tertiary hospital].
Topics: Adolescent; Cell Cycle Proteins; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Connexins; Co | 2015 |
NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement.
Topics: Adolescent; Brain; Cell Cycle Proteins; Central Nervous System; Charcot-Marie-Tooth Disease; Deafnes | 2007 |
A 71-nucleotide deletion in the periaxin gene in a Romani patient with early-onset slowly progressive demyelinating CMT.
Topics: Age of Onset; Base Sequence; Charcot-Marie-Tooth Disease; Child, Preschool; Demyelinating Diseases; | 2008 |